Stocktoria
NeuroSense Therapeutics Ltd. NRSN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-12-09
NeuroSense Therapeutics Ltd. statistics & valuation
Market cap$26.8M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Return on assets | -1082.2% | -223.2% | -317.3% |
| Return on equity | 713.1% | -395.3% | 574.6% |
| Current ratio | 0.31 | 2.21 | 0.84 |
Source: SEC EDGAR filings · CIK 0001875091 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.